ArticleOncotarget2019

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate.

Leonidas Apostolidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.